MB ChB Year 1: Nutrition and Energy

Pharmacology

The following drugs, or drug groups are mentioned during this ICU. You should complete a drug profile sheet (available to download from the VLE) for each drug on the list. Drugs in italics have been mentioned in previous ICUs, though often in different clinical contexts.

You will be expected to know the condition(s) for which the relevant drugs are prescribed, and, where this is well understood, how the drug works.

DRUG
CONDITION FOR WHICH USED
NOTES
cimetidine
peptic ulcers
Work session 1+lecture 8
PPIs (omeprazole)
peptic ulcers
Work session 1+lecture 8
NSAIDS (aspirin, ibuprofen)
 
gastric side-effects (peptic ulcers)Work session 1
misoprostol
peptic ulcers - in association with NSAID use
Work session 1
loperamide
"traveller's diarrhoea"
Work session 3
mesalazine
inflammatory bowel disease
Work session 3+lecture 5
corticosteroids
(prednisolone, hydrocortisone)
inflammatory bowel disease
anaphylaxis (food allergy)
Addison's disease
Work session 3+lecture 5

Work session 9+ lecture 24
6-mercaptopurine
inflammatory bowel disease
Work session 3+lecture 5
infliximab
inflammatory bowel disease
Work session 3+ lecture 5
adrenalin
anaphylaxis (food allergy)
Work session 3
antihistamines (H1 antagonists)
anaphylaxis (food allergy)
Work session 3
ethanol
 
dependence, overdose, interaction with other drugs
Work session 5
benzodiazepines
treatment of symptoms of alcohol dependence
Work session 5
disulphuram
treament of alcohol dependence
Work session 5
naltrexone
treament of alcohol dependence
Work session 5
acamprosate
treament of alcohol dependence
Work session 5
insulin
diabetes
lecture 21 + Dr Ajjan's lecture
sulphonyl ureas (glicazide)
type 2 diabetes
lecture 21 + Dr Ajjan's lecture
biguanides (metformin)
type 2 diabetes
lecture 21 + Dr Ajjan's lecture
a-glycosidase inhibitors
type 2 diabetes
lecture 21 + Dr Ajjan's lecture
glitazones
type 2 diabetes
lecture 21 + Dr Ajjan's lecture
statins (lovastatin)
hypercholesterolaemia
Work session 8+ lecture 17
orlistat
obesity
obesity seminar + lecture 26
carbamizole
Grave's disease
Work session 9+ lecture 24